Dasatinib is an anti-cancer drug that can target tyrosine kinase-related SCAPs, while quercetin is a natural plant flavonoid that inhibits the BCL-2/BCL-XL, PI3K/AKT, and p53/p21/serpine SCAPs48. This evidence concerns the gene BCL2L1 and cancer.